eoadjuvant immunochemotherapy using intratumoral injection of dendritic cells for thoracic esophageal cancers

Phase 1

• Conditions: Thoracic esophageal cancers

• Registration Number: JPRN-UMIN000000669
• Lead Sponsor: Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-09-01
• Study Completion: 2011-07-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

Patients with serious concomitant disease Patients with autoimmune disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of adverse event